We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Innovative Catheter Guidance Technology Aims for Zero Malpositioning

By HospiMedica International staff writers
Posted on 17 Sep 2024
Print article
Image: The PM2 System with ECGuide Connector (Photo courtesy of Piccolo Medical)
Image: The PM2 System with ECGuide Connector (Photo courtesy of Piccolo Medical)

Millions of catheters are still being inserted each year without the use of guidance, posing unnecessary risks to patients. Blind insertions require confirmation through chest X-ray, which increases hospital costs, exposes patients to more radiation, and delays the start of medication infusion. Now, a new catheter guidance technology that utilizes intravascular cardiac electrical activity (ECG) offers an alternative method for confirming proper catheter placement, eliminating the need for chest X-rays.

Piccolo Medical (San Francisco, CA, USA) has developed the ECGuide technology, which uses the patient's ECG to determine the catheter tip position in real time. It has been approved as a substitute for chest X-rays to confirm correct catheter placement. While catheter guidance systems are commonly used in Peripherally Inserted Central Catheter (PICC) procedures, their adoption for Central Venous Catheter (CVC) procedures in the U.S. has been limited. Studies have shown that intravascular ECG technology enhances accuracy in both CVC and PICC placements and reduces complication rates.

Piccolo has now received clearance from the U.S. Food and Drug Administration (FDA) to market its PM2 System with ECGuide Connector, an innovative catheter guidance technology. This addition to Piccolo's product portfolio is aimed at reducing complications associated with central venous catheter insertions, a procedure that impacts over 8 million patients annually.

"Millions of catheters are still being inserted without guidance every year," said Augustus Shanahan, CEO of Piccolo Medical. "The evidence is clear: blind insertions pose unnecessary risks to patients and incur additional costs for hospitals. With the launch of ECGuide, we aim to overcome barriers related to cost and complexity, ultimately driving the industry towards a goal of zero malpositioning."

Related Links:
Piccolo Medical

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Patient Warming Blanket
Patient Warming Blanket
New
CPAP Machine
EcoStar Auto

Print article

Channels

Critical Care

view channel
Image: Associate Professor Lisa Zhu and Wenyi Hu investigated the use of an AI eye test in GP clinics (Photo courtesy of CERA)

AI Eye Scans Could Help Identify Heart Disease and Stroke Risk

New research has explored the advantages of utilizing artificial intelligence (AI) retinal imaging for screening cardiovascular diseases in general practice (GP) clinics and highlighted areas where improvements... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.